Phase
Condition
Acute Respiratory Distress Syndrome (Ards)
Treatment
N/AClinical Study ID
Ages < 90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Clinically stable preterm infants with birth weights ≤1500g admitted to the neonatalintensive care unit (NICU) at the Children's and Women's Hospital of BC
On nasal continuous positive airway pressure of 6 to 8 cmH20 support for at least 48hours, treated with methylxanthines for apnea of prematurity and requiring 21-40% ofoxygen.
Exclusion
Exclusion Criteria:
infants with congenital anomalies of the gastrointestinal tract, phrenic nerve damage,diaphragmatic paralysis, esophageal perforation.
infants with congenital or acquired neurological deficit (including significantintraventricular hemorrhage >Grade II), neonatal seizure.
infants with significant congenital heart disease (including symptomatic PDA).
infants with congenital anomalies of the diaphragm.
infants with congenital anomalies of the respiratory tracts (e.g. Congenital CysticAdenomatoid Malformation (CCAM)).
infants requiring ongoing treatment for sepsis, necrotizing enterocolitis (NEC),antibiotics for lung infections, narcotic analgesics, or gastric motility agents.
infants on nasal CPAP and requiring more than 40% oxygen
infants with significant gastric residuals and vomiting.
infants with facial anomalies.
infants with pneumothorax or pneumomediastinum.
infants in the immediate postoperative period.
Study Design
Study Description
Connect with a study center
British Columbia Women's Hospital and Health Centre
Vancouver, British Columbia V6H 3N1
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.